2022 EULAR Recommendations for ANCA-associated Vasculitis
EULAR has published the 2022 update on recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
AAV recommendations were last published in 2016, and since, research and clinical trials have advanced our understanding of AAV. A
Read Article